Related Experiment Video
Updated: Oct 20, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Early Prediction of Tacrolimus-Induced Tubular Toxicity in Pediatric Refractory Nephrotic Syndrome Using Machine
Xiaolan Mo1,2, Xiujuan Chen3, Chifong Ieong2
1Department of Pharmacy, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Abstract:
Background and Aims: Tacrolimus(TAC)-induced nephrotoxicity, which has a large individual variation, may lead to treatment failure or even the end-stage renal disease. However, there is still a lack of effective models for the early prediction of TAC-induced nephrotoxicity, especially in nephrotic syndrome(NS). We aimed to develop and validate a predictive model of TAC-induced tubular toxicity in children with NS using machine learning based on comprehensive clinical and genetic variables. Materials and Methods: A retrospective cohort of 218 children with NS admitted between June 2013 and December 2018 was used to establish the models, and 11 children were prospectively enrolled for external validation. We screened 47 clinical features and 244 genetic variables. The changes in urine N- acetyl- β-D- glucosaminidase(NAG) levels before and after administration was used as an indicator of renal tubular toxicity. Results: Five machine learning algorithms, including extreme gradient boosting (XGBoost), gradient boosting decision tree (GBDT), extremely random trees (ET), random forest (RF), and logistic regression (LR) were used for model generation and validation. Four genetic variables, including TRPC6 rs3824934_GG, HSD11B1 rs846910_AG, MAP2K6 rs17823202_GG, and SCARB2 rs6823680_CC were incorporated into the final model. The XGBoost model has the best performance: sensitivity 75%, specificity 77.8%, accuracy 77.3%, and AUC 78.9%. Conclusion: A pre-administration model with good performance for predicting TAC-induced nephrotoxicity in NS was developed and validated using machine learning based on genetic factors. Physicians can estimate the possibility of nephrotoxicity in NS patients using this simple and accurate model to optimize treatment regimen before administration or to intervene in time after administration to avoid kidney damage.
Insights
This study developed a machine learning model to predict tacrolimus (TAC)-induced nephrotoxicity in children with nephrotic syndrome (NS). The model uses genetic factors to identify patients at risk, enabling early intervention and optimized treatment strategies.
Area of Science:
- Pharmacogenomics
- Nephrology
- Machine Learning in Medicine
Background:
- Tacrolimus (TAC) is crucial for nephrotic syndrome (NS) but causes variable nephrotoxicity, potentially leading to end-stage renal disease.
- Effective early prediction models for TAC-induced nephrotoxicity, particularly in NS patients, are lacking.
- This study addresses the need for predictive tools to mitigate TAC-related kidney damage.
Purpose of the Study:
- To develop and validate a machine learning model for predicting TAC-induced tubular toxicity in children with NS.
- To identify key clinical and genetic variables associated with TAC nephrotoxicity.
- To enable personalized treatment strategies for NS patients receiving TAC.
Main Methods:
- A retrospective cohort of 218 NS children was used for model development, with prospective validation in 11 children.
- Machine learning algorithms (XGBoost, GBDT, ET, RF, LR) were employed.
- Urine N-acetyl-β-D-glucosaminidase (NAG) levels served as the indicator for renal tubular toxicity, alongside 47 clinical and 244 genetic features.
Main Results:
- The XGBoost model demonstrated the best performance with 75% sensitivity, 77.8% specificity, 77.3% accuracy, and 78.9% AUC.
- Four genetic variables (TRPC6 rs3824934_GG, HSD11B1 rs846910_AG, MAP2K6 rs17823202_GG, SCARB2 rs6823680_CC) were significant predictors.
- The model effectively predicted TAC-induced nephrotoxicity in NS patients.
Conclusions:
- A robust, machine learning-based predictive model for TAC-induced nephrotoxicity in NS patients was successfully developed and validated.
- The model, utilizing genetic factors, allows for pre-administration risk assessment.
- This tool can guide physicians in optimizing TAC treatment regimens and preventing kidney damage.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Drug Excretion: Tubular Secretion
Renal Drug Excretion: Tubular Reabsorption
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

